Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Neurology
•
Neuro-immunology
Do you consider steroid-sparing agents for treatment of patients with steroid responsive relapsed Hashimoto Encephalopathy?
Related Questions
How does one interpret an SPEP showing potentially obscured but non-quantifiable M-spike however an IFE showing monoclonal protein?
What is the diagnostic approach and management for suspected Hashimoto Encephalitis?
What is your treatment approach to neuropsychiatric symptoms secondary to lupus?
How frequently do you recommend ordering labs to monitor for side effects of disease-modifying therapies for multiple sclerosis?
What treatment do you use for stroke prevention in cervical artery dissection?
When do you consider pembrolizumab for the treatment of progressive multifocal leukoencephalopathy?
For stroke patients with ablated paroxysmal atrial fibrillation without known recurrence and ICAD, would you recommend dual antiplatelet therapy or anticoagulation with or without an antiplatelet agent?
When do you attribute tremors to lamotrigine?
What is your approach to immune management in opsoclonus-myoclonus-ataxia syndrome?
Do you prescribe respiratory muscle training (RMT) devices to patients with dysphagia?
